feed,title,long_url,short_url
Benzinga,Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis,https://www.benzinga.com/pressreleases/20/08/g17149032/galapagos-announces-that-gilead-received-a-complete-response-letter-for-filgotinib-for-the-treatme,https://j.mp/3iXuLCr
